PHARMACOKINETICS AND SAFETY/TOLERABILITY OF KL1333, A NOVEL AGENT FOR PRIMARY MITOCHONDRIAL DISORDERS IN HEALTHY MALE SUBJECTS.-MedSci.cn

PHARMACOKINETICS AND SAFETY/TOLERABILITY OF KL1333, A NOVEL AGENT FOR PRIMARY MITOCHONDRIAL DISORDERS IN HEALTHY MALE SUBJECTS.

Yang, E; Yoo, H; Ban, M; Huh, K; Kim, Y; Jang, IJ; Yoon, S; Yu, KS

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019; 105 (): S20

科室
- - 订阅+
  - 更多科室
工具
服务